跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP
Authorized
STANDARD
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP
hikma canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
705040d33b510270
Company
hikma canada limited
Type
Standard
Approval Details
Approval Id
705040d33b510270
Drug Approval Canada Name
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP
Product Name
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP
Status
Marketed
Status Date
2023-09-22
Original Market Date
2016-01-12
Din
02436221
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Block/Infiltration
Schedule
Ethical
Ahfs
72:00.00
Atc Original
N01BB52 LIDOCAINE, COMBINATIONS
Atc Name
n 01 bb 52
Aig Number
0201284005
Company Name
hikma canada limited
Company Address
5995 Avebury Road, Suite 804, Mississauga, Ontario, Canada, L5R 3P9
Active Ingredients
LIDOCAINE HYDROCHLORIDE
20 MG / ML
EPINEPHRINE (EPINEPHRINE BITARTRATE)
0.01 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
705040d33b510270
Type
Standard
Back to Health Canada Approvals